en.Life News

14/10/2026

🧠 Ne întâlnim la Care4Cancer 2026!

EnLife Medical & News participă ca partener al evenimentului, susținând educația medicală, inovația și schimbul de experiență.

📍 Hotel Mercure Arsenal Sibiu
📅 14–17 octombrie 2026

Dragi medici, vă invităm la standul EnLife să descoperiți soluții moderne pentru neurochirurgia craniană și spinală, să explorați implanturile și materialele disponibile și să discutați cu echipa noastră despre nevoile practicii dumneavoastră.

Veniți cu întrebări și idei. Haideți să discutăm despre următorul pas în neurochirurgie!

EducatieMedicala

12/10/2026

📣Chirurgia Ortognatică 360°: Ocluzie, Respirație, Implanturi și Estetica Feței 15–17 Octombrie 2026 ·

09/10/2026

Eurospine, 2026
Gothenberg, Sweden Day 3(8.10.26)

08/10/2026

Modern surgery advances through education, practice and the exchange of experience. Day 2 of the Romanian Shoulder and Elbow Meeting – SRUC / RESS 2026, held at K2 Alpin in Poiana Brașov, highlighted the growing importance of highly specialised education in Romanian orthopaedics. The scientific p...

08/10/2026

SRUC 2026 – Day 1 | When highly specialised education moves medicine forward

08/10/2026

Event details We’re excited to be part of neuroRAD 2026, the 61st Annual Meeting of the German Society of Neuroradiology (DGNR). ● October 7–9, 2026 ● Rheingoldhalle Mainz, Germany ● Booth 211 Under the theme “Next Generation – The Future is Now,” the congress brings together leading...

08/10/2026

Event details Celebrate 40 years of excellence in cardiothoracic surgery at the 40th EACTS Annual Meeting – Honouring our History, Inspiring our Future. Join the world’s largest gathering of the cardiothoracic surgical community to connect with leading experts, explore pioneering innovations and...

05/10/2026

https://en.life/2026/10/05/ivascular-presents-1-year-results-of-the-ilico-study-at-cirse-2026/

One-year data shows a 96.7% Freedom from TLR and a 90.3% Primary Patency with iCover in a study population that includes all types of iliac lesions. Barcelona, September 3, 2026. iVascular announces the presentation of the final                     1-year results of the iliCo stu...

05/10/2026

Phase II efficacy data in 70 patients show a 98.6% total occlusion rate, with 0% microcatheter entrapment, 0% material migration and no-device-related events identified. Barcelona, September 3, 2026. New Phase II data from the OPAL study, evaluating iVascular’s novel liquid embolic Amber ahead of ...